Smart Investor Malaysia

Previous
Next
Previous
Next

Mediven® and Tune Protect team up to offer Diagnostic Screening and COVID-19 insurance coverage via MyDocLabTM

Facebook
Twitter
LinkedIn
WhatsApp
Telegram

Medical Innovation Ventures Sdn. Bhd. (Mediven®), Tune Protect and MyDocLabTM today officially launched their community care collaboration which offers COVID-19 insurance coverage and diagnostic screening via mobile app, MyDocLabTM.

The unique tripartite collaboration is touted as a first in the market with the merging of innovation, insurance protection and diagnostic screening. Mediven® test kit users can now enjoy the added bonus of insurance coverage at no extra costs.

Mediven® Executive Director, En Ariff Ismail explained, “This initiative is timely as the nation moves into the endemic phase and communities learn to live with the virus. Our Community Care Collaboration is designed to offer peace of mind and double protection; all within convenience of one’s mobile phone. Users of Mediven®’s  ProDetect® self-test kits will receive an allowance if tested positive for COVID-19 Category three and above. Users will also be protected with accidental death and total permanent disability benefits. The coverage is valid for 14 days upon submission of their test results via MyDocLab.

Mediven®, a Penang-based medical diagnostic company which develops, manufactures, and markets advanced high quality clinical diagnostic molecular and rapid tests, is the manufacturer of ProDetect® self-test kits, approved by the Malaysia Medical Device Authority (MDA).

Explaining Tune Protect’s involvement, Group CEO, Mr Rohit Nambiar commented, “Tune Protect’s partnership in this collaboration is very much in line with our business aspirations. We aim to make insurance simplified and accessible for everyone. With the power of technology and through this collaboration, we are one step closer to providing protection anytime, anywhere at the convenience of the fingertips. We are truly honoured to be the official insurance partner to offer value added insurance protection to Mediven® Covid test kit users which will be a relief for Covid positive patients.”

Mediven® Operations Director, Dr Lim Li Sze, added, “Protection is key in everyone’s mind as we go through this trying and prolonged health challenge. This community care collaboration allows us to extend double protection in terms of diagnostic screening and insurance coverage to protect ourselves, our families, our workplaces and the community at large.”

MyDocLabTM users can also tap on the multi-featured digital platform to conduct virtually-supervised screenings for Medical Device Authority (MDA) approved test kits, made possible through partnerships with select private clinics and laboratories. Travellers arriving in Malaysia who must undergo a professionally administered RTK within 24 hours of arrival can also opt to perform their self-test within the comforts of their home or quarantine centre via the app. Same day result anytime, anywhere are guaranteed. 

In addition, the app also allows bookings for real-time PCR, rapid antigen and post-vaccination neutralising antibody tests at clinics and laboratories. Travellers may also purchase travel insurance with a COVID-19 cover as required by the Malaysian government.

Additionally, Human Resource managers of corporate companies will also find the MyDocLabforWork  feature helpful as it essentially helps companies effectively manage and track their employees’ health status through a hassle-free process.

Dr Lim said that they are working closely with partner pharmacies to educate consumers on the double protection of insurance and diagnostic screening offered to assist them in these endemic times. Mediven® ProDetect® COVID-19 test kits (saliva or nasal formats) are available in most major chain pharmacies and retails outlets such as Alpro, AMPM, CARiNG, Georgetown, Watsons, Wellings, Be Pharmacy and 7-Eleven.

About Mediven®

Medical Innovation Ventures Sdn. Bhd. (Mediven®) is an award winning and leading molecular diagnostics provider in Malaysia reputed to deliver fast, flexible, reliable and intelligent proprietary diagnostic tools with its GenoAmpTM and ProDetectTM series of products. Backed by its strong collaborative ties with research institutions both locally and abroad, Mediven’s in-house R&D team has carved a stellar reputation for the design, development and manufacture of innovative diagnostic products that address early and fast detection of infectious diseases prevalent in developing countries. Mediven® has received numerous accolades over the years such as the Frost & Sullivan Malaysia Excellence Award (2016) and the Ernst & Young’s Entrepreneur of The Year Award (2018). Most recently, Mediven® received the Commercialisation Achievement Award 2021 from the Ministry of Science, Technology and Innovation, Malaysia.

For more information : www.medivencom.my

About MyDocLabTM

MyDocLabTM , a one-stop digital healthcare mobile app, provides quality health screening services and products for individuals as well as corporate HR managers needing to manage employees’ health status. Its convenient and seamless accessibility to diagnostic & healthcare services promises a shorter turnaround timing for diagnostic testing, automated and professionally adminstered ART/RTKs and self-management of healthcare status.

For more information : www.mydoclab.com

About Tune Protect Malaysia

Tune Insurance Malaysia Berhad (“Tune Protect Malaysia”) is a licensed insurer that has a geographically diverse presence in Malaysia, with 18 branches nationwide, and our Head Office strategically located in Kuala Lumpur. Tune Protect Malaysia provides a comprehensive range of general insurance solutions through multiple distribution channels to balance the needs of different consumer groups. We are supported by dedicated agents, brokers and direct clients to underwrite various general insurance classes.

For more information : www.tuneprotect.com

Join our Telegram to get the latest from Smart Investor
Facebook
Twitter
LinkedIn
WhatsApp
Telegram

Recent Posts

Related Posts

Smart Investor Newsletter

Get Our Latest Articles And More Delivered To Your Inbox!